Meeting
2016 ASCO Annual Meeting
ORCA-2: A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck.
Authors
Martin David Forster
University College London, London, United Kingdom
Martin David Forster , Ruheena Mendes , Kevin J. Harrington , Teresa Guerrero Urbano , Helen Baines , Victoria J Spanswick , Leah Ensell , John A. Hartley , Sola Adeleke , Paul Gougis , David Leader , Cathy McDowell , Andre Lopes , Jonathan Teague , Sharon Forsyth , Sandy Beare
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Local-Regional Disease
Clinical Trial Registration Number
NCT02308072
Citation
J Clin Oncol 34, 2016 (suppl; abstr TPS6108)
DOI
10.1200/JCO.2016.34.15_suppl.TPS6108
Abstract #
TPS6108
Poster Bd #
426b
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
A phase I study of the PI3K inhibitor buplarlisib (B) with concurrent chemoradiotherapy (CRT) in patients with high risk locally advanced squamous cell cancer of the head and neck (LASCCHN).
First Author: Jochen H. Lorch
Poster
2022 ASCO Annual Meeting
Six-year follow-up from the weekly-three-weekly study comparing cisplatin once-a-week to once-every-three-weeks as concurrent chemoradiation for locally advanced head and neck squamous cell carcinoma.
First Author: Vanita Noronha
Poster
2018 ASCO Annual Meeting
A phase I dose-finding study of metformin in combination with concurrent cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma.
First Author: Shuchi Gulati
Poster
2012 ASCO Annual Meeting
Phase II trial of chemoradiotherapy concurrent with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck (SCCHN): Results of the Japan Clinical Oncology Group study, JCOG 0706.
First Author: Makoto Tahara